Form 8-K - Current report:
SEC Accession No. 0001437749-21-007874
Filing Date
2021-03-31
Accepted
2021-03-31 17:09:02
Documents
15
Period of Report
2021-03-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20210330_8k.htm   iXBRL 8-K 28587
2 EXHIBIT 99.1 ex_238402.htm EX-99.1 11928
7 logo01.jpg GRAPHIC 9001
  Complete submission text file 0001437749-21-007874.txt   192104

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acrx-20210330.xsd EX-101.SCH 3700
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20210330_def.xml EX-101.DEF 11586
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20210330_lab.xml EX-101.LAB 15466
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20210330_pre.xml EX-101.PRE 11740
8 EXTRACTED XBRL INSTANCE DOCUMENT acrx20210330_8k_htm.xml XML 2565
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 21794489
SIC: 2834 Pharmaceutical Preparations